BI 671800 in Asthmatic Patients on Inhaled Corticosteroids

Completed · Phase 2 · Has a placebo group

Conditions studied: Asthma

In brief

This is a 6 week study to assess the effect of BI 671800 in patients with asthma. It is a double blind, parallel arm trial testing the safety and efficacy of BI 671800. The main objective is to assess the effect on lung function. The study will also provide data on the pharmacokinetics of BI 671800.

Key facts

Study ID
NCT01103349
Run by
Boehringer Ingelheim
People needed
243
Starts
2010-04-20
Expected to finish
2011-08-09
Last updated by the study team
2022-05-31

Who can join

Age: 18 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.